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THE MODIFIED FONTAN 
OPERATION 
An analysis of risk factors 
for early postoperative 
death or takedown in 702 
consecutive patients from 
one institution 
To better understand risk factors associated with early postoperative death or 
failure, we reviewed our entire experience with 702 consecutive patients who had the 
modified Fontan operation at the Mayo Clinic between October 1973 and December 
1989. The event rate for takedown of repair or death during the initial hospitaliza- 
tion or within 30 days of the operation was 14.8% (successful takedown of the repair, 
n = 6; death, n = 98). To identify variables associated with early death or Fontan 
takedown, we analyzed 33 clinical and hemodynamic variables in a univariate and 
multivariate manner. On the basis of a stepwise logistic discriminant analysis, patients 
who were younger and operated on before 1980 with a higher preoperative pulmonary 
artery mean pressure, asplenia, higher intraoperative (after Fontan operation) right 
atrial pressure, longer aortic crossclamp time, and pulmonary artery ligation were more 
likely to have the outcome vent of interest (p values <0.05). A new variable, corrected 
pulmonary artery pressure (that is, mean preoperative pulmonary artery pressure 
divided by the ratio of pulmonary to systemic flow if the ratio of pulmonary to systemic 
flow is greater than 1.0), was significantly associated with the outcome vent univariately 
(p = 0.002), but was no more predictive than the preoperative pulmonary artery mean 
pressure. Variables less predictive of the outcome event in this analysis included 
multiple prior operations, polysplenia syndrome, complex anatomy other than asplenia 
syndrome, and systemic atrioventricular valve regurgitation. These results represent the 
largest single-institution review of the Fontan operation and suggest hat some anatomic 
and hemodynamic variables previously predictive of poor early outcome have been 
nullified by current operative methods. (J THORAC CARDIOVASC SURG 1995;109:1237-43) 
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S ince the first successful Fontan operation for tricuspid atresia was reported in 1971,1 numer- 
ous modifications have been proposed as definitive 
palliation for an increasing variety of complex cya- 
notic congenital heart defects with a functional 
single ventricle. 2-19 More recently, surgical modifi- 
cations have focused on staging the separation of 
systemic and pulmonary circulations 9-13 in an at- 
tempt to reduce the early mortality and morbidity 
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associated with the modified Fontan operation in 
patients with higher risk factors. 
As experience was gained with the modified Fon- 
tan operation at the Mayo Clinic and more patients 
with complex cyanotic heart disease requiring a 
one-ventricle repair were referred, our selection 
criteria were broadened to accommodate these 
high-risk patients, often with encouraging early re- 
sults. 2°-24 However, apart from modifications for 
specific technical difficulties, 3'4, 6, 25 the operation 
has remained essentially unchanged throughout the 
years, allowing this analysis of risk factors for early 
failure to be undertaken with little influence of 
surgical variation. 
Patients and methods 
Study group. Since the first operation at the Mayo 
Clinic in October 1973 and as of the end of 1989, 702 
consecutive patients had the modified Fontan operation. 
These 702 patients form the basis of this review. All but 8 
of these 702 patients known to be alive at the date of the 
most recent follow-up had more than 30 days of postop- 
erative follow-up. 
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The age at operation ranged from 8 months to 42 years, 
and the median age was 9 years. Forty percent of the 
patients were female. The primary cardiac defect was 
tricuspid atresia in 203 (28.9%), double-inlet ventricle in 
226 (32.2%), and complex cardiac defects in 273 (38.9%). 
Surgical technique. The surgical techniques have been 
described fully elsewhere 15' 18, 21 and may be summarized 
as follows: the operation usually was done with the use 
of deep hypothermia (20 ° to 25 ° C) facilitated by periods 
of low-flow perfusion (0.5 to 1.5 L/min per square 
meter) or circulatory arrest as necessary. Intermittent cold 
blood or crystalloid cardioplegia and topical hypothermia 
were used for myocardial protection. Direct atriopulmo- 
nary connection was the preferred anastomosis for tricus- 
pid atresia nd double-inlet left ventricle. In most patients 
with univentricular heart, the systemic and pulmonary 
venous drainage was partitioned in such a way that the 
coronary sinus drained into the pulmonary venous ide of 
the atrial baffle, but no special techniques were used to 
achieve this if the anatomy was unfavorable. Partial 
Fontan techniques such as the fenestrated Fontan proce- 
dure,12, 13, 26 adjustable atrial septal defect Fontan proce- 
dure,3O, 11, 27 hemi-Fontan or bidirectional cavopulmonary 
shunt, or both the latter procedures together 9" 28, 29 were 
not used, and variations of the total cavopulmonary 
connection or lateral atrial tunnel repair 3' 5, 3o were only 
used for anomalies of systemic or pulmonary venous 
drainage, as previously described. 
Outcome event. The outcome vent for this study was 
defined as takedown of the repair or death during the 
initial hospitalization orwithin 30 days of the operation. 
Statistical analysis. Associations between the outcome 
event and 33 clinical and hemodynamic variables (Tables 
I and II) were analyzed univariately by the )(2 test or 
Fisher's exact est, or both, for dichotomous variables and 
the Wilcoxon rank-sum test for continuous and ordinal 
variables. A stepwise multiple logistic discriminant analy- 
sis was used to identify factors jointly associated with the 
outcome vent after the modified Fontan operation. Vari- 
ables were retained in the multivariate analysis if their p 
values were less than 0.05. The odds ratios and corre- 
sponding 95% confidence intervals for each statistically 
significant variable were then calculated on the basis of 
the estimated coefficients obtained from the logistic 
model. 
From the final logistic model, an estimated predicted 
probability of having the outcome vent was obtained for 
each patient. The sensitivity of the model was defined as 
the proportion of patients who had the event who each 
had a model-predicted probability higher than a given 
cutoff value, whereas pecificity was the proportion of 
patients who did not have the event who had model- 
predicted probabilities below the cutoff value. 
Results 
The mortality rate during the initial hospitaliza- 
tion or within 30 days of the operation was 14.0% 
(n = 98) and an additional 6 of 16 patients urvived 
takedown of the repair, for a combined event rate of 
14.8% (n = 104). This rate has significantly dimin- 
ished over the years from 26.6% before 1980 to 
13.0% since 1980 (p < 0.001) (Table III) despite the 
increased number of high-risk patients currently 
undergoing operation. 
Univariate analysis. Patients who had the out- 
come event were more likely to have a complex form 
of functional single ventricle, asplenia, ligation of 
the pulmonary artery, higher intraoperative right 
atrial pressure (before and after the Fontan opera- 
tion) and higher intraoperative l ft atrial pressure 
(after the Fontan procedure), higher preoperative 
and intraoperative (before Fontan procedure) pul- 
monary artery mean pressure, longer aortic cross- 
clamp time, larger heart size (preoperative cardio- 
thoracic ratio), higher ventricular end-diastolic 
pressure, and younger age and lower body weight at 
the time of operation (Tables I and II, p < 0.05). 
Concomitant repair or replacement of the atrioven- 
tricular valve was of marginal significance (p = 
0.057). 
A new variable, "corrected pulmonary artery 
pressure," was also examined. This is defined as 
mean pulmonary artery pressure divided by the ratio 
of pulmonary to systemic flow (Qp/Qs) (if Op/Qs is 
greater than 1.0) or, if Qp/Qs is 1.0 or smaller, mean 
pulmonary artery pressure divided by unity. Al- 
though this was highly significant (p = 0.002), it was 
no more predictive than preoperative pulmonary 
artery mean pressure and therefore was not in- 
cluded in the multivariate model. 
Multivariate analysis. On the basis of a stel~wise 
logistic discriminant analysis, seven variables were 
identified as associated with the outcome event of 
interest: year of operation before 1980, presence of 
asplenia, younger age at operation, higher preoper- 
ative pulmonary artery mean pressure, longer aortic 
crossclamp time, pulmonary artery ligation, and 
higher intraoperative right atrial pressure (after 
Fontan procedure) (Table IV). At a specificity of 
80%, the sensitivity for this model was 73%. 
Discussion 
The Fontan-type repair may be the definitive 
palliation for a variety of complex cyanotic heart 
defects. During the past decade, the indications for 
the modified Fontan operation were extended to 
patients with more complex lesions 2' 4-6, 15-16, 24-25 and 
to patients who fulfilled fewer and fewer of the widely 
accepted criteria for low-risk operation]' 17-19, 21, 31 AS- 
sociated with this enthusiasm for the Fontan repair 
came a better understanding of the hemodynamics 
and pathophysiologic features of the repair s, 26, 32-37 
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Table I. Univariate relations between dichotomous 
or ordinal demographic/clinical variables and early 
postoperative death or takedown 
No. of 
Factor (% missing)* patients 
Takedown 
and~or 
hospital 
death 
% p Value 
Gender 
Male 
Female 
Lesion 
Complex 
Other 
Polysplenia 
Yes 
No 
Asplenia 
Yes 
No 
Enlargement ofbulbar ven- 
tricular foramen 
Yes 
No 
Left and/or right pulmonary 
artery reconstruction 
Yes 
No 
AV valve repair or replace- 
ment 
Yes 
No 
Preoperative AV valve 
insufficiency 
None 
Mild 
Moderate 
Severe 
Preoperative pulmonary AV 
fistula 
Yes 
No 
Division of pulmonary 
artery 
Yes 
No 
Ligation of pulmonary 
artery 
Yes 
No 
AV valve patch closed 
Yes 
No 
Preoperative atrial arrhyth- 
mia 
Yes 
No 
Valved connection 
Yes 
No 
422 
280 
273 
429 
46 
656 
46 
656 
16 
14 
19 
12 
22 
14 
35 
13 
59 17 
643 15 
154 14 
548 15 
66 23 
636 14 
459 15 
152 13 
45 16 
46 22 
18 17 
684 14 
257 12 
445 16 
245 20 
454 12 
228 15 
466 15 
66 12 
636 15 
52 13 
650 15 
0.450 
0.012 
0.171 
<0.001 
0.630 
0.834 
0.057 
0.620 
0.740 
0.119 
0.005 
0.970 
0.518 
0.773 
Table I. Cont'd 
Takedown 
and~or 
hospital 
death 
No. of 
Factor (% missing)* patients % p Value 
Pulmonary arteriolar resis- 
tance index (39%) 
<2 297 14 0.238 
2-4 117 16 
5+ 13 31 
NYHA fimctional c ass (32%) 
I 8 13 0.121 
II 252 15 
III 207 20 
IV 9 22 
Intraoperative (after Fontan) 
RA pressure 
>20 110 37 <0.001 
<-20 574 9 
Intraoperative (after Fontan) 
LA pressure 
>10 273 19 0.001 
<-10 387 10 
Ventricular end-diastolic 
pressure (15%) 
>15 158 16 0.664 
<-15 440 15 
Ejection fraction (52%) 
<-50 104 14 0.347 
>50 231 11 
Age (yr) 
<4 84 25 0.005 
>-4 618 13 
Weight (kg) 
-<15 131 24 0.001 
>15 567 13 
All variables are preoperative m asurements except for intraoperative 
right and left atrial pressure measurements. AV, Atrioventricular; NYHA, 
New York Heart Association; RA, right atrial; LA, left atrial. 
*Percentage of patients with missing data. 
and improved perioperative management, allof which 
translated into better early results. As experience was 
gained, newer surgical innovations became available to 
deal with the most complex of lesions, 24' 8-9,15, 3o, 38 to 
reduce the frustrating early morbidity related to the, 
postoperative accumulation of persistent or recurrent 
serous fluids, 5' 10-11, 26, 39-4o to improve the hemody- 
namics by possibly streamlining the systemic venous 
channels,5, 3oand to support he patient during fluctu-- 
ations in cardiac output and pulmonary vascular esis.- 
tance. 
More recently, we 21'23 and others 1°'41-42 have 
cautioned against the application of the Fontan 
principle to patients who were less than ideal can- 
didates for the operation, indicating that not only 
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Table II. Univariate relations between continuous demographic~clinical v riables and early postoperative death 
or takedown 
Factor 
Early postoperative d ath or takedown 
Overall No (n = 598) Yes (n = 104) 
percent 
missing Median Mean Range Median Mean Range p Value 
Age (yr) 0 9.0 
No. of prior procedures 0 1 
Intraoperative (before Fontan) RA pressure 31 8 
(ram Hg) 
Intraoperative (before Fontan) PA mean 47 13 
pressure (ram Hg) 
Intraoperative (after Fontan) RA pressure 3 18 
(ram Hg) 
Intraoperative (after Fontan) LA pressure 6 10 
(ram Hg) 
Crossclamp time (rain) 8 68 
Preoperative CT ratio 10 0.55 
Preoperative PA mean pressure (ram Hg) 15 16 
Preoperative Op/Qs 33 1.18 
Pulmonary arteriolar resistance index 39 1.4 
(ram Ug/L/min • m 2) 
Total pulmonary resistance (ram Hg/L/ 43 3.7 
min- m 2) 
Ventricular end-diastolic pressure (ram Hg) 15 12 
Preoperative ejection fraction (%) 52 57 
Weight (kg) 1 26.2 
PA mean pressure/(Qp/Qs)* 37 12.0 
11.0 0.66-42.0 6.0 8.0 0.66-29.0 <0.001 
1.3 0-6 i 1.5 0-7 0.181 
8.5 1-25 9 9.9 2-23 0.046 
14.2 3-53 16 18.1 5-58 0.002 
17.7 8-30 20 20.2 9-34 <0.001 
9.9 2-23 11 11.5 3-25 <0.001 
71.1 4-199 76 79.9 5-189 0.026 
0.55 0.29-0.81 0.59 0.58 0.42-0.82 0.003 
18.0 2-73 19.5 22.2 8-58 <0.001 
1.56 0.15-9.00 1.34 1.57 0.22-6.50 0.921 
1.6 0.1-5.6 1.5 1.8 0.2-4.5 0.247 
4.1 0.5-11.6 3.8 4.4 0.8-14.0 0.288 
12.7 5-32 14 14.0 5-34 0.023 
55.7 30-82 55.5 56.0 34-78 0.852 
31.8 5.9-99.0 18.5 24.0 5.7-79.5 <0.001 
12.6 0.9-34.8 13.0 14.9 2.4-30.4 0.002 
RA, right atrial; PA, pulmonary artery; LA, left atrial; CT, cardiothoracic. 
*If Qp/Qs >1 or pulmonary artery mean pressure/i; if Qp/Qs -<1. 
Table I l l .  Distribution of  early postoperative death 
or takedown by year of  operation 
Takedown and/ 
or hospital death 
Year of No. of 
operation patients No. % 
1973 1 0 - -  
1974 3 2 67 
1975 4 1 25 
1976 5 1 20 
1977 10 2 20 
1978 19 2 11 
1979 52 17 33 
Subtotal 94 25 27 
1980 41 9 22 
1981 48 9 19 
1982 60 11 18 
1983 50 5 10 
1984 59 6 10 
1985 70 9 13 
1986 74 11 15 
1987 66 8 12 
1988 73 3 4 
1989 67 8 12 
Subtotal 608 79 13 
Total 702 104 15 
was the attr it ion rate high during the first 6 months 
after operat ion,  but also that late complicat ions 
d~veloped in a significant proport ion of patients 
after the repair,  including arrhythmias, 23-43 protein- 
losing enteropathy, 44-46 and progressive cardiac fail- 
ure and death. 2°' 23, 4~-42 Recent  modif ications uch 
as the bidirect ional  G lenn anastomosis,  fenestrated 
Fontan procedure,  and adjustable atr ial-septal  de- 
fect after the Fontan operat ion may reduce signifi- 
cantly the per ioperat ive morbidity and mortality. 
Whether  this will translate into better  long-term 
survival is unfortunately still unknown. 
In the long term there may be advantages to 
earl ier operat ions uch as minimizing the deleteri-  
ous effects of ventr icular hypertrophy, chronic vol- 
ume overload, and deter iorat ing cardiac func- 
tion. 17'41'42 However,  in our experience, which 
spans 16 years and in which two surgeons (G. K. D. 
and F. J. P.) each per formed more than 300 modi-  
fied Fontan  operat ions on patients whose ages 
ranged from 8 months to 42 years, pat ients younger 
than 4 years still have a greater  risk of dying or 
having the repair  taken down after operat ion than 
do older patients. The discrepancy of this risk, 
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Table IV. Summary of logistic discriminant analysis 
Estimated 
beta 
Variable coefficient Delta Odds ratio* (95% CI) p Value 
Intraoperative (after Fontan) RA pressure 0.235 
Operation before 1980 (yes vs. no) 1.649 
Age (yr) -0.096 
Preoperative PA mean pressure 0.060 
Asplenia (yes vs. no) 1.080 
Crosselamp time (rain) 0.011 
Ligation of PA (yes vs. no) 0.605 
2 1.60 (1.31, 1.94) <0.001 
1 5.20 (2.45, 11.04) <0.001 
-3  1.33 (1.14, 1.57) <0.001 
3 1.20 (1.10, 1.30) <0.001 
1 2.94 (1.17, 7.40) 0.022 
8 1.09 (1.01, 1.18) 0.024 
1 1.83 (1.04, 3.22) 0.036 
C/, confidence interval; RA, right atrial; PA, pulmonary artery. 
*Estimated odds of having an event per delta unit change in the value of each variable. 
however, has decreased with more recent year of 
operation. Most surgeons currently think that the 
optimal age for the modified Fontan operation in 
uncomplicated cases hould be 2 to 4 years]' 17-19, 47 
Our data may be influenced adversely by the dispro- 
portionate number of patients with many risk factors 
(in addition to younger age). Indeed, we have 
reported that in patients at low risk the mortality for 
the 2- to 4-year-old patients is no different from that 
of older patients. 18 
However, it is important o emphasize that a 
major limitation of a retrospective study such as this 
one is the unavailability of complete data on all 
patients. For example, a measurement of preopera- 
tive ejection fraction was unavailable for 52% of the 
patients in this study. In addition, a clinical selection 
process may exclude patients with presumed adverse 
risk factors from the cohort. Both of these factors 
will prevent he identification of important predic- 
tive variables. 
Although higher pulmonary arteriolar esistance 
is unquestionably animportant risk factor, we could 
not identify it as an independent variable in this 
analysis. This may reflect both the narrow range 
within which patients are accepted for operation 
and the high proportion (_+40%) of patients in 
whom data for this variable were missing. It is 
reasonable, however, to assume that both higher 
preoperative pulmonary artery mean pressure and 
higher postoperative right atrial pressure (both 
highly significant determinants of an event in this 
analysis) reflect elevated pulmonary vascular esis- 
tance. 
We were somewhat surprised to find that the new 
variable corrected pulmonary artery pressure was 
not more predictive of an event han simply the use 
of the pulmonary artery mean pressure. Again, the 
37% missing data may have diminished the statisti- 
cal significance of this new concept. Motivation for 
the development of this variable derived from the 
clinical situation in which a patient with a pulmo- 
nary artery pressure of, for example, 24 mm Hg is 
evaluated for operation. If the Qp/Qs in this patient 
is, for example, 2:1 and this is restored to 1:1 by the 
operation, then the pulmonary artery pressure may 
be expected to be reduced to 12 mm Hg (24/2) after 
operation. 
The need for reconstruction of the pulmonary 
arteries, significant systemic atrioventricular valve., 
regurgitation, and the number of previous opera-. 
tions were not determinants of an event in this 
study. Because the follow-up period was restricted 
to hospital discharge or 30 days after operation, we; 
did not assess whether these factors were still pre.- 
dictive of a poor long-term outcome. 23 
Though our results with this subgroup have im- 
proved over the years, 4 the heterotaxia splenia 
syndrome remains a significant determinant of an 
event in this study. This reflects the complex cardiac 
pathologic features present and the complicated 
intracardiac baffles necessary to separate the circu- 
lations. However, the significance of pulmonar.¢ 
artery ligation as a risk factor is less clear: 502 of the 
702 patients in this study had either ligation (n = 
245) or division (n = 257) of the main pulmonary 
artery, and although division of the main pulmonary 
artery is not statistically important (p = 0.119), 
ligation of the pulmonary artery was significant both 
univariately (p = 0.005) and multivariately (p = 
0.036). Whether this is a confounding variable, a 
positive variable (for example, ligation may occa- 
sionally result in some distortion of either the 
branch pulmonary arteries or even closely related 
coronary arteries), or a negative variable (for exam- 
pie, not ligating the pulmonary artery and allowing a 
small amount of prograde flow through a severely 
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obstructive pulmonary artery may be beneficial in 
the short term) is extremely difficult o determine in 
a retrospective analysis uch as this. 
From the multivariate analysis it is evident hat 
younger age, higher preoperative pulmonary artery 
mean pressure, higher postrepair ight atrial pres- 
sure, early year of operation, presence of asplenia 
syndrome, longer aortic crossclamp time, and liga- 
tion of the pulmonary artery are important determi- 
nants of an event in this analysis (Table IV). For this 
model at a specificity of 80%, the sensitivity was 
73%. 
One should, however, be cautious when drawing 
conclusions from this study, because the end point 
for an event is early postoperative death or Fontan 
takedown. Although this allows for easy comparison 
with other studies, agood outcome by this definition 
does not necessarily reflect a satisfactory overall 
result, because the attrition rate is known to be 
higher for the first 6 months after operation. TM 41-42 
This is an important major limitation of an analysis 
such as this. However, the objective of the study was 
to relate the risk analysis for early postoperative 
death or takedown in our patient cohort to that of 
previous studies to determine whether any risk 
factors have been nullified by experience and time, 
both within our practice and relative to other large 
series. 
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